Literature DB >> 15962391

Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.

Wei Zhang1, Er-Xun Ding, Qiang Wang, Da-Qiao Zhu, Jin He, Yu-Li Li, Yuan-He Wang.   

Abstract

AIM: To detect the expression of Fas ligand (FasL) in colon cancer tissues and cell lines and analyze the function of FasL-expressing colon cancer cells in inducing Fas-sensitive T lymphocyte apoptosis.
METHODS: Ninety surgically resected colon cancer tissues and 15 hepatic metastasis specimens were investigated by immunohistochemical method with normal colon mucosa and colon adenoma as control. The relationship between FasL expression and pathologic features was also analyzed. FasL expression of 4 colon cancer cell lines, SW620, Lovo, LS-174T and SW1116, were detected by Western blotting assay. The function of FasL expressed on colon cancer cells was determined by coculture assay with Jurkat T lymphocytes, the apoptotic rate of which was detected by flow cytometry assay.
RESULTS: Fifty-six (62.22%) cases of all the 90 colon cancer tissues and all (100%) the liver metastasis specimens expressed FasL, significantly higher than normal colon mucosa and colonic adenoma. Higher expression of FasL was found in more advanced stage of colon cancer and in cancer tissues with lymphatic or hepatic metastasis. All the colon cancer cell lines were found to express FasL. After coculture with the SW1116 cells for 24 h with an effector: target ratio 10:1, the rate of apoptosis of Jurkat cells rose from 1.9% to 21.0%.
CONCLUSION: The expression of FasL is upregulated in colon cancer and the functionally expressed FasL can induce apoptosis of Fas-expressing T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962391      PMCID: PMC4315977          DOI: 10.3748/wjg.v11.i23.3632

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients.

Authors:  Caroline Bäumler; Fei Duan; Kenan Onel; Beth Rapaport; Suresh Jhanwar; Kenneth Offit; Keith B Elkon
Journal:  Leuk Res       Date:  2003-09       Impact factor: 3.156

2.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

4.  Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; D Roche; J Kelly; J K Collins; F Shanahan
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

5.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

6.  Prognostic relevance of altered Fas (CD95)-system in human breast cancer.

Authors:  M Mottolese; S Buglioni; C Bracalenti; M A Cardarelli; L Ciabocco; D Giannarelli; C Botti; P G Natali; A Concetti; F M Venanzi
Journal:  Int J Cancer       Date:  2000-03-20       Impact factor: 7.396

7.  Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer.

Authors:  Sug Hyung Lee; Hong Sug Kim; Su Young Kim; Yun-Sil Lee; Won Sang Park; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo
Journal:  APMIS       Date:  2003-02       Impact factor: 3.205

8.  Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

Authors:  S Strand; W J Hofmann; H Hug; M Müller; G Otto; D Strand; S M Mariani; W Stremmel; P H Krammer; P R Galle
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

9.  [The role of Fas/Fas ligand in tumorgenesis, immune escape, and counterattack in colonic cancer].

Authors:  Qiang Zhu; Changsheng Deng
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2002-06

10.  Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression.

Authors:  A Houston; M W Bennett; G C O'Sullivan; F Shanahan; J O'Connell
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

View more
  12 in total

1.  Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.

Authors:  Guillaume Sarrabayrouse; Cindy Synaeve; Kevin Leveque; Gilles Favre; Anne-Françoise Tilkin-Mariamé
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

Review 2.  Colon cancer and the immune system: the role of tumor invading T cells.

Authors:  Maximilian Waldner; Carl-C Schimanski; Markus-F Neurath
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

3.  miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7.

Authors:  Ming-Fu Wu; Jie Yang; Tao Xiang; Yan-Yan Shi; Li-Jiang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

Review 4.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  Polymorphonuclear Neutrophils and Tumors: Friend or Foe?

Authors:  Izabela Szulc-Kielbik; Magdalena Klink
Journal:  Exp Suppl       Date:  2022

6.  SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.

Authors:  Chunwan Lu; John D Klement; Dafeng Yang; Thomas Albers; Iryna O Lebedyeva; Jennifer L Waller; Kebin Liu
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

7.  Apoptosis - an Ubiquitous T cell Immunomodulator.

Authors:  Anuradha K Murali; Shikhar Mehrotra
Journal:  J Clin Cell Immunol       Date:  2011-12-10

8.  CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.

Authors:  Charalabos Pothoulakis; Monica Torre-Rojas; Marco A Duran-Padilla; Jonathan Gevorkian; Odysseas Zoras; Emmanuel Chrysos; George Chalkiadakis; Stavroula Baritaki
Journal:  Int J Cancer       Date:  2017-10-12       Impact factor: 7.316

Review 9.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

10.  Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.

Authors:  Jianming Wu; Maureen H Richards; Jinhai Huang; Lena Al-Harthi; Xiulong Xu; Rui Lin; Fenglong Xie; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.